Table 2.

Comparison of two groups by using the EORTC QLQ C30 and BR23 questionnaires

	PM + MLDF	M + I	p value
Global health statusa	83.3 (0–100)	83.3 (33.3–100)	0.21
Physical functiona	86.6 (26.6–100)	93.3 (33.3–100)	0.012
Role functiona	100 (0–100)	100 (50–100)	0.053
Emotional functiona	83.3 (0–100)	83.3 (33–100)	0.705
Cognitive functiona	100 (0–100)	100 (0–100)	0.175
Social functiona	83.3 (0–100)	66.6 (17–100)	0.205
Financial problemsb	33.3 (0–100)	33.3 (0–100)	0.58
Dyspneab	0 (0–100)	0 (0–66.6)	0.483
Painb	16.6 (0–100)	16.6 (0–100)	0.155
Nausea/vomitingb	0 (0–66.6)/3.04	0 (0–16.6)/0.29	0.024
Fatigueb	33.3 (0–100)	33.3 (0–88.8)	0.214
Sleep disturbancesb	0 (0–100)/21.1	0 (0–100)/14.8	0.057
Appetite lossb	0 (0–100)	0 (0–66.6)	0.384
Constipationb	0 (0–100)	0 (0–100)	0.663
Diarrheab	0 (0–100)	0 (0–67)	0.155
Systemic therapy side effectsb	11 (7–28)	11 (7–24)	0.858
Arm symptomsb	22.2 (0–100)	22.2 (0–78)	0.511
Breast symptomsb	8.3 (0–100)	0 (0–67)	0.055
Upset by hair lossb	6.38 ± 15.23	4.35 ± 15.04	0.440
Body imagea	75 (0–100)	58.3 (0–100)	0.000
Future perspectivea	66.6 (0–100)	66.6 (0–100)	0.926
Sexual functiona	4 (1–12)	4 (2–12)	0.165
Sexual enjoymenta	5.34 ± 14.33	3.37 ± 12.24	0.298

Mann-Whitney U test

^athe higher values indicate higher level of functioning and quality of life; min: 0, max: 100

^bthe higher values indicate a greater severity of symptoms, min: 0, max: 100